Correlation Between Sarepta Therapeutics and BIONTECH

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and BIONTECH at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and BIONTECH into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and BIONTECH SE DRN, you can compare the effects of market volatilities on Sarepta Therapeutics and BIONTECH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of BIONTECH. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and BIONTECH.

Diversification Opportunities for Sarepta Therapeutics and BIONTECH

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Sarepta and BIONTECH is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and BIONTECH SE DRN in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BIONTECH SE DRN and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with BIONTECH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BIONTECH SE DRN has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and BIONTECH go up and down completely randomly.

Pair Corralation between Sarepta Therapeutics and BIONTECH

Assuming the 90 days trading horizon Sarepta Therapeutics is expected to generate 1.31 times more return on investment than BIONTECH. However, Sarepta Therapeutics is 1.31 times more volatile than BIONTECH SE DRN. It trades about 0.02 of its potential returns per unit of risk. BIONTECH SE DRN is currently generating about -0.01 per unit of risk. If you would invest  2,937  in Sarepta Therapeutics on August 24, 2024 and sell it today you would earn a total of  275.00  from holding Sarepta Therapeutics or generate 9.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.6%
ValuesDaily Returns

Sarepta Therapeutics  vs.  BIONTECH SE DRN

 Performance 
       Timeline  
Sarepta Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sarepta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
BIONTECH SE DRN 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BIONTECH SE DRN are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, BIONTECH sustained solid returns over the last few months and may actually be approaching a breakup point.

Sarepta Therapeutics and BIONTECH Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sarepta Therapeutics and BIONTECH

The main advantage of trading using opposite Sarepta Therapeutics and BIONTECH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, BIONTECH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIONTECH will offset losses from the drop in BIONTECH's long position.
The idea behind Sarepta Therapeutics and BIONTECH SE DRN pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities